Skip navigation
Unable to save this job. Please try again later.


Email this Job to Yourself or a Friend

To begin the application process, please enter your email address.

Company Contact Info

  • Bernards, NJ 07920

Already have an account?

Sign in to apply with your saved resumes.

New to CareerBuilder?

Don't have an account? Continue as a guest!

Sorry, we cannot save or unsave this job right now.

Report this Job

Trust and Site Security Team.

Email Send Failed!

Director, Medical Publications & Communications, GMA

Daiichi Sankyo, Inc. • Bernards, NJ

Posted 10 days ago

Job Snapshot

Other Great Industries
Health Care, Pharmaceutical


How Do You Compare to the Competition?

Get facts about other applicants with a CareerBuilder Account

Job Description

About Daiichi Sankyo Cancer Enterprise
The vision of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking in order to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Anchored by our Antibody Drug Conjugate (ADC) and Acute Myeloid Leukemia (AML) Franchises, our cancer pipeline includes more than 20 small molecules, monoclonal antibodies and ADCs stemming from our powerful research engines: our two laboratories for biologic/immuno-oncology and small molecules in Japan, and Plexxikon Inc., our small molecule structure-guided R&D center in Berkeley, CA. Compounds in development include: quizartinib, an oral FLT3 inhibitor, for newly-diagnosed and relapsed/refractory AML with FLT3-ITD mutations; DS-8201, anADCfor HER2-expressing breast cancer and gastric cancer or other HER2-expressing solid tumors; and pexidartinib, an oral CSF-1R inhibitor, for tenosynovial giant cell tumor (TGCT), which is also being explored in a range of solid tumors in combination with the anti-PD1 immunotherapy pembrolizumab. For more information, please visit:

Job Summary:
The Director, Global Medical Affairs (GMA) works with the Global Franchise Head AML and Executive Director GMA medical communications & publications and with Director GMA publications oversight, supports the development of a global publication strategy for the AML franchise and the different compounds, lead the development of the publication plan(s) and the plan implementation in alignment with, GMA AML Franchise head and clinical development. Director GMA medical communications & publications oversee the development of global medical communication and education and training content.

  • Taking a lead of global publication implementation team for AML franchise to develop global publication tactical plan support the development global publications strategy and support medical communication plan development by translating medical/publication strategy into actions.
  • Leading implementation of global publication plan for AML franchise by reflecting regional publication needs and by working with vendors. Integrated in the GMA AML franchise and compound plan.
  • Managing global publication review committee (PRC) process and adhering to internal publications policies in execution of global process and manuscript review.
  • Management of publication review process of all publications for AML, including but not limited to abstracts, posters, oral presentations, and manuscripts from a global and regional levels as applicable.
  • Develop material and execute projects for internal and external scientific and medical education/training.
  • Oversee the development of a global medical education &training content across therapeutic areas in collaboration with the therapeutic areas.
  • Oversee the review and quality check (QC) of global scientific and commercial material for internal and external use.
  • Attend or chair working groups related to global communication and publication projects.
  • Represent Global Medical Affairs position on communication and publication in global teams.
  • Develop work-stream/project-related budget plans in collaboration with Global Medical Lead and work-stream leader.
  • Collaborate with the GMA AML Franchise and Medical Director and execution of the medical communication plan (publications, medical slides, and satellite symposia) and provide critical review of materials as needed.
  • Collaboration and alignment with relevant functions across regions to align the publication strategy for the franchise.
  • Collaborate with the Global Medical functions, work-stream lead and respective team members to ensure robust medical strategic plans for the Oncology AML franchise and respective products.
Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

  • PharmD, or PhD in Health Sciences preferred; training or experience in therapeutic area is required. Bachelor’s Degree or Advanced Degree in Health Sciences may be considered pending years of experience/qualifications.
  • Minimum of 3-5 years of pharmaceutical industry, clinical, and/or academic experience for, PharmD, or PhD; Minimum of 5 years of pharmaceutical industry experience or 7 years with publication/communication agency for Bachelor’s or MS degree in health sciences. Proven track record of working successfully with cross-functional teams to achieve goals. Experience with publication planning is required. Previous experience in Therapeutic Area is required. Experience with clinical trials is preferred.
  • Basic knowledge and appropriate application of biostatistics; proficiency using standard software suites.
  • Excellent written and oral communication skills, particularly strong formal presentation skills; strong interpersonal skills; possession of strong scientific analytical skills; excellent planning and organizational skills; experience in managing budgets; understanding of good publication practices and guidance.
  • Experience in the development of medical educational and training material.
  • Experience in the development and execution of medical communication/education and training platforms.
Ability to travel up to 20%

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
Job ID: 9030BR
Help us improve CareerBuilder by providing feedback about this job: Report this Job.
For your privacy and protection, when applying to a job online, never give your social security number to a prospective employer, provide credit card or bank account information, or perform any sort of monetary transaction. Learn more.
By applying to a job using CareerBuilder you are agreeing to comply with and be subject to the CareerBuilder Terms and Conditions for use of our website. To use our website, you must agree with the Terms and Conditions and both meet and comply with their provisions.